Exact Sciences Corporation
EXAS
NSC
Sector: Healthcare
Industry: Diagnostics & Research
49.37
USD
1.78
(3.74%)
Optionable: Yes Market Cap: 8,433 M 90-day average vol: 2,118,948
Previous close: 47.59 Open: 47.88 Bid: 49.95 Ask: 49.95
52 week range
35.34 108.99
Last updated: Friday 5th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 5.95 |
Price per Book TTM ($) | 2.55 |
PE Ratio (TTM) | -10.90 |
Book Value per Share ($) | 18.52 |
5 Year PE Range | -140.3 , -22.9 |
Returns
7 Day Return | 6.72% | |
1 Month Return | 11.19% | |
3 Month Return | -10.24% | |
1 Year Return | -53.35% | |
3 Year Return | -54.49% | |
5 Year Return | 25.94% | |
YTD Return | -36.57% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 59.64 |
14 Day SMA ($) | 46.70 |
14 Day EMA ($) | 46.77 |
Money Flow Index | 36.30 |
Average True Range | 2.69 |
50 Day SMA ($) | 45.00 |
200 Day SMA ($) | 67.30 |
ADX | 22.47 |
MACD | 0.74 |
Growth
Free Cash Flow QoQ Growth | 146.98% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -18.75% |
Revenue QoQ Growth | 2.69% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Diversey Appoints Katherine S. Zanotti to its Board of Directors
Yahoo Finance 3/1/2022
Exact Sciences to participate in March investor conferences
Yahoo Finance 2/28/2022
10 Stocks in Focus After Posting Their Earnings Reports
Yahoo Finance 2/24/2022
Invest in Next-Gen Technologies With These 2 ETFs
Yahoo Finance 2/24/2022
Exact Sciences Corporation 2021 Q4 - Results - Earnings Call Presentation
Seeking Alpha 2/23/2022
Cancer-Test Maker Exact Sciences Saw Strong Revenue Growth
Yahoo Finance 2/23/2022
Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down
Yahoo Finance 2/23/2022
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 2/22/2022
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 2/22/2022
Exact Sciences cuts quarterly loss 47%, but still misses on bottom line consensus
Seeking Alpha 2/22/2022
Exact Sciences GAAP EPS of -$1.28 misses by $0.44, revenue of $473.81M beats by $26.25M
Seeking Alpha 2/22/2022
Exact Sciences Announces Fourth Quarter 2021 Results
Yahoo Finance 2/22/2022
Exact Sciences Q4 2021 Earnings Preview
Seeking Alpha 2/21/2022
3 Stocks to Avoid This Week
Yahoo Finance 2/21/2022
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Yahoo Finance 2/18/2022
A First Take On Exact Sciences
Seeking Alpha 2/16/2022
Here’s Why You Should Remain Optimistic in Exact Sciences Corp. (EXAS)
Yahoo Finance 2/16/2022
Cathie Wood’s Ark Invest files to to launch venture fund
Yahoo Finance 2/10/2022
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
Yahoo Finance 2/9/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -1.915
Financials
EXAS Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 4 M | 4 M | 2 M | 39 M | 99 M | 266 M | 454 M | 876 M | 1,491 M | 1,767 M |
| Cost of sales | -2 M | -2 M | -252000 | 15 M | 33 M | 48 M | 77 M | 135 M | 119 M | 188 M |
| Gross operating profit | 4 M | 4 M | -3 M | 15 M | 54 M | 202 M | 358 M | 694 M | 1,207 M | 1,394 M |
| Selling Gen & administrative expense | 14 M | 23 M | 69 M | 140 M | 190 M | 263 M | 427 M | 738 M | 1,048 M | 1,663 M |
| Research & development expense | 42 M | 28 M | 29 M | 34 M | 33 M | 42 M | 67 M | 140 M | 554 M | 386 M |
| Operating income | -53 M | -47 M | -100 M | -159 M | -169 M | -118 M | -159 M | -234 M | -558 M | -836 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | 262000 | 316000 | 542000 | 1 M | 2 M | 4 M | 21 M | 16 M | -254 M | 12 M |
| Pre-tax Income (EBT) | -52 M | -46 M | -100 M | -158 M | -167 M | -115 M | -175 M | -269 M | -829 M | -843 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | -187000 | 92000 | -185 M | -5 M | -247 M |
| Net income from total operations | -52 M | -46 M | -100 M | -158 M | -167 M | -114 M | -175 M | -84 M | -824 M | -596 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -52 M | -47 M | -100 M | -158 M | -167 M | -114 M | -175 M | -84 M | -824 M | -596 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -52 M | -46 M | -100 M | -158 M | -167 M | -114 M | -175 M | -84 M | -824 M | -596 M |
| Depreciation | 2 M | 2 M | 5 M | 9 M | 12 M | 16 M | 20 M | 47 M | 165 M | 185 M |
| Amortization | 0 | 0 | 0 | 0 | 0 | 983000 | 3 M | 16 M | 93 M | 95 M |
| Operating income before depreciation (EBITDA) | -51 M | -45 M | -96 M | -150 M | -155 M | -99 M | -117 M | -170 M | -654 M | -649 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -0.88 | -0.69 | -1.25 | -1.71 | -1.63 | -0.99 | -1.43 | -0.64 | -5.61 | -3.48 |
| Diluted EPS total | -0.88 | -0.69 | -1.25 | -1.71 | -1.63 | -0.99 | -1.43 | -0.64 | -5.61 | -3.48 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!